DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Mycoplasma Testing Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 - 2023" report to their offering.
The global mycoplasma testing market is expected to grow with the CAGR of approximately 13.4% during the forecast period (2016-2023).
The mycoplasma market is primarily driven due to various factors such as increasing funding for life science researches, increasing number of biotechnology & pharmaceutical firms, increasing demand for PCR based assays, increasing prevalence of mycoplasma infection across the globe and technological developments such as PCR technique. Commercial PCR tests having advantages in diagnosing M. pneumoniae infections as PCR is most reliable method for the detection of mycoplasma infection because it is not easy to culture mycoplasma on artificial media. Serology could be good and reliable screening tests for accurate diagnosis of M. pneumoniae. Numerous PCR methods based on 16SrDNA amplification comprise one- or two-step nested PCRs to identify mollicutes.
Various methods is used for isolation of highly purified nucleic acids which is ideal for use in PCR and primarily used for detection of large number of samples. Increasing technological advancements enables to develop effectiveness and accuracy of testing and provides more accurate results. However, there are some factors restraining the market growth such as stringent government regulations and high cost associated with mycoplasma testing. Moreover, increasing healthcare spending in developing countries and growth in pharmaceutical outsourcing is creating opportunity for the mycoplasma testing market.
- ATCC Company (U.S.)
- Biological Industries (U.S.)
- Bionique Testing Laboratories, Inc. (U.S.)
- Charles River Laboratories, Inc. (U.S.)
- Eurofins Scientific S.A. (U.S.)
- Gibraltar Laboratories Inc. (U.S.)
- Invivogen (U.S.)
- Lonza Group (Switzerland)
- Merck Millipore (U.S.)
- Meridian Bioscience, Inc. (U.S.)
- Minerva Biolabs Gmbh (Germany)
- Promocell Gmbh (Germany)
- R&D Systems, Inc. (U.S.)
- Roche Diagnostics (Switzerland)
Thermo Fisher Scientific Inc. (U.S.)
Key Topics Covered:
2. Market Overview
3. Market Determinants
4. Market Segmentation
5. Competitive Landscape
6. Geographical Analysis
7. Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/98ts5z/global_mycoplasma